z-logo
open-access-imgOpen Access
THE EFFECT OF LOW VERSUS HIGH DOSE OF ANTI-SNAKE VENOM ON OUTCOMES AND ADVERSE EFFECTS IN SNAKE BITE CASES AT M.G.M. MEDICAL COLLEGE AND HOSPITAL, JAMSHEDPUR, JHARKHAND: A CROSS-SECTIONAL OBSERVATIONAL STUDY
Author(s) -
Sanjay Kumar Pandey,
Vikram Murmu,
Paulami Sarkar,
Debarshi Jana
Publication year - 2020
Publication title -
international journal of scientific research
Language(s) - English
Resource type - Journals
ISSN - 3046-5206
DOI - 10.36106/ijsr/1425007
Subject(s) - medicine , adverse effect , medical prescription , emergency medicine , microsoft excel , medical emergency , toxicology , pharmacology , computer science , biology , operating system
Background: Snakebite is a significant problem in rural India. It is an occupational hazard and causes considerable morbidity and mortality. It is a significant financial burden on victims and hospitals. Fortunately, these bites are eminently treatable and curable. A lack of universal consensus for the dose of Anti Snake Venom(A.S.V.) exists. Low vs. high dose is the most debated topic. Dose-related adverse effects are enduring issues in the snake bite management protocols.Objective: To observe the effects of the low and high dose of A.S.V. on results and side effects in snake bite cases in MGMM COLLEGE and hospital in Jharkhand, India.Materials and Methods: We did a cross-sectional in the medical emergency and intensive care unit ofM.G.M. Medical College, Jamshedpur. We analyze the prescriptions of 58 snakebite patients admitted to the I.C.U/emergency. We analyzed data during the study period of 3 months. We used descriptive statistics and Microsoft Excel 2007. Fisher's Exact Test is used to analyze statisticallyResult: A.K.I. was found in 5 (21%) low dose group and 9 (26%) high dose group, patients with neuroparalysis required ventilator/Ambu bag support in 3 (13%) low dose group and 6 (18%) patients high dose group. The hospital stay duration was 3.98 for the low dose group and 5.22 days for the high dose group. The mortality rate was 4% in the low dose group versus 6% in the high dose group. The manifestation of adverse effects of A.S.V. was also found to be significantly low in a low dose A.S.V. groupConclusion: we compared treatment outcomes and found low doses of A.S.V. may be utilized to optimize the effective dose and minimize its adverse effects. A beneficial trend for the low-dose group is seen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom